Drug Topics

JULY 5, 2023

How does AI help reduce the burden on specialist dermatology services and help simplify the screening process?

180

180

Pharmacy Times

JULY 5, 2023

Pharmacists can use their knowledge and professional judgment to educate patients about when it is appropriate to take these medications and when to avoid them.

132

132

Drug Topics

JULY 5, 2023

Although it is widely known that probiotics have anti-inflammatory effects and can alleviate clinical symptoms of atopic dermatitis (AD) in children, the effects of probiotics on AD in children have long been controversial.

98

98

Pharmacy Times

JULY 5, 2023

Adam C. Welch, PharmD, MBA, FAPhA, and Chad Worz, PharmD BCGP, FASCP, discusse the development of recombinant and cell-based vaccines and the new types of flu vaccines being explored.

Vaccines 123

Vaccines 123

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Pharma

JULY 5, 2023

Despite political tensions between Washington and Beijing, foreign pharmaceutical investments are progressing in China. | In a deal that could be worth up to $1 billion, Massachusetts-based Moderna inked a memorandum of understanding, plus a land collaboration agreement, to research, develop and manufacture mRNA medicines in China.

118

118

Pharmacy Times

JULY 5, 2023

An expert panel discussed the outreach of social determinants of health in community pharmacy care and how pharmacists can help patients find and access resources.

Community Pharmacies 123

Community Pharmacies 123

Pharmacy Times

JULY 5, 2023

To slow the production of MCI and dementia, utilizing more ways of establishing the diagnoses for women can prevent the progression.

120

120

Fierce Healthcare

JULY 5, 2023

Hospital outpatient departments are marking up the prices for biologic medicines more than physician offices, particularly for “innovator biologics” that have clinically equivalent and lower cost a | Consistently higher markups among hospital outpatient departments hamstring potential savings payers may hope to see down the line as more biosimilars become available, warned the Employee Benefit Research Institute.

Hospitals 110

Hospitals 110

PharmExec

JULY 5, 2023

Rose Blackburne, MD, MBA, vice president, global head, general medicine, PPD Clinical Research, Thermo Fisher Scientific, discusses health equity in pharma, specifically racial biases, and how the industry can address inequities in access and care going forward.

105

105

Fierce Healthcare

JULY 5, 2023

The quality bonus program (QBP) that rewards Medicare Advantage (MA) plans fails to achieve its two main goals: fairly rewarding MA insurers that actually improve quality and encouraging beneficiar | The Medicare Advantage Quality Bonus Program suffers from what some experts call the “Lake Wobegon Effect”: Too many plans are rated above average. A new Urban Institute report suggests some cures.

Insurance 110

Insurance 110

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

JULY 5, 2023

WASHINGTON – Novo Nordisk spent $11 million on meals and travel for thousands of doctors last year, federal records show, as part of its push to promote Ozempic and other weight loss-inducing diabetes drugs. The pharmaceutical company bought more than 457,000 meals to educate doctors and other prescribers about its portfolio of drugs known as GLP-1 agonists, according to the newly released data from the Centers for Medicare and Medicaid Services.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

Fierce Pharma

JULY 5, 2023

While the price of just about everything has increased over the last six years in the U.S., the same can’t be said for the cost of an FDA priority review voucher. Just ask Sarepta Therapeutics. | The price of priority review vouchers is falling. Just ask Sarepta Therapeutics. Since 2017, the company has sold off three PRVs—getting less in return for each successive sale.

FDA 105

FDA 105

Fierce Healthcare

JULY 5, 2023

Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, payers and other industry players look to expand their businesses and gain a competitive edge. | Bright Health exits insurance business, Vandalia Health to add three hospitals, Centene divests AI platform and more M&A news from the month of June.

Insurance 105

Insurance Hospitals 105

Outsourcing Pharma

JULY 5, 2023

Lucy Jung is the CEO and founder at Charco Neurotech, a medtech start-up which has developed the CEU1, a non-invasive wearable device for Parkinson's, that uses vibrotactile stimulation to reduce symptoms of slowness and stiffness resulting in improved movement. We spoke to her about her background, how she got involved in the Parkinson's space and her fascination for problem-solving.

104

104

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

JULY 5, 2023

The blood pressure drug could provide relief for veterans and service members suffering from traumatic brain injuries.

123

123

Fierce Pharma

JULY 5, 2023

Amneal Pharmaceuticals’ hopes for a midyear launch of its extended-release Parkinson’s disease prospect—and a shot at a potential $500 million peak sales opportunity in the U.S.—have been put on ic | The FDA has rebuffed Amneal’s application for IPX203, an oral formulation of carbidopa/levodopa, which leverages a unique delivery formula in a bid to increase “on” time without troublesome dyskinesia.

FDA 102

FDA 102

STAT

JULY 5, 2023

With summer in full swing, it’s a great time to tuck into a new book or podcast. Whether you’re looking for gripping personal stories or fascinating histories of deadly pathogens, our annual list of health, medicine, and science titles has something for everyone. Read on for recommendations from the likes of Deputy CDC Director Nirav Shah, Boston Public Health Commission Executive Director Bisola Ojikutu, and Gavi CEO Seth Berkley.

98

98

The Checkup by Singlecare

JULY 5, 2023

Having a sunburn can be irritating, painful, and uncomfortable. But when it becomes itchy on top of that, you might feel downright exasperated! Sunburn itch varies in intensity. If you’ve ever been plagued by the throbbing, painful itch that can accompany a particularly severe sunburn, then you’ll understand why it’s sometimes called “hell’s itch.” It usually lasts for a few days or up to a week.

Health and Personal Care Stores 98

Health and Personal Care Stores 98

STAT

JULY 5, 2023

Black Americans who live in neighborhoods with lower levels of income and education may age faster than their white neighbors, according to a new study. This can be true even when an individual Black person has a higher income or education level — underscoring the extent to which a person’s surroundings can impact their health. The study , published Wednesday in PLOS ONE, builds on an emerging body of research that links faster biological aging, measured by a process called DNA met

98

98

Drug Store News

JULY 5, 2023

CHPA also requested a meeting with FDA’s leadership to ensure the proposed organization structure would not dilute the prioritization of dietary supplements.

FDA 104

FDA 104

STAT

JULY 5, 2023

The U.S. National Institutes of Health late last month halted further funding for a pair of malaria research facilities in Colombia after authorities filed charges against the operators for lacking permits to experiment on monkeys and causing “harm to wildlife.” The move came more than six months after the People for the Ethical Treatment of Animals notified both the U.S. agency and Colombian authorities of problems at the Caucaseco Scientific Research Center and Malaria Vaccine De

Vaccines 98

Vaccines 98

Drug Topics

JULY 5, 2023

Boehringer Ingelheim’s Cyltezo is the first and only FDA-approved interchangeable biosimilar to adalimumab.

FDA 98

FDA 98

STAT

JULY 5, 2023

When children living with HIV are injected with neutralizing antibodies, the treatment can suppress cells that contain the virus and are capable of reactivating, an early-stage trial found. Details of the trial, documented in a study published Wednesday in Science Translational Medicine, show that broadly neutralizing antibodies can boost the protective effects of antiretroviral drugs.

Documentation 95

Documentation 95

Fierce Pharma

JULY 5, 2023

Go for the Gulf: Sanofi partners with local drugmakers to crank out vaccines at new manufacturing plant in Saudi Arabia fkansteiner Wed, 07/05/2023 - 15:19

Vaccines 98

Vaccines 98

Pharmaceutical Technology

JULY 5, 2023

Following FDA approival and CE marking for Incyte’s JAK-inhibiting cream Opzelura (ruxolitinib), the MHRA has followed suit in the UK.

FDA 105

FDA 105

Fierce Pharma

JULY 5, 2023

Another FDA accelerated approval has run its course, with Roche giving up on a niche indication for cancer drug Gavreto. | Another accelerated approval has run its course, with Roche giving up on a niche indication for cancer drug Gavreto. The move comes as the Swiss pharma giant prepares to terminate a collaboration with Blueprint Medicines.

FDA 91

FDA 91

STAT

JULY 5, 2023

Good morning, everyone, and nice to see you again after an extended holiday break, at least for many on this side of the pond. We hope the last few days have been refreshing and invigorating, no matter what you were up to. As for us, we are easing back in to the usual routine as we prepare for online calls and deadlines. Some things never change. So to get started, we are brewing a cup of stimulation, which we understand continues to have some worthwhile attributes.

90

90

Fierce Pharma

JULY 5, 2023

Gilead and Teva have chalked up an important legal victory in a California court, defeating allegations that they created an anticompetitive scheme to delay generic competition to lucrative HIV tre | Gilead and Teva were accused of conspiring to keep HIV generics off the market in a 2019 lawsuit seeking $3.6 billion in damages. The two companies already settled part of the case in May.

88

88

Drug Store News

JULY 5, 2023

The annual event, which honors trailblazers and rising stars across the industry, will take place from Nov. 14-15 at the Sheraton Grand Chicago Riverwalk.

92

92

STAT

JULY 5, 2023

An effective treatment for Alzheimer’s disease has long been a holy grail in the pharmaceutical industry. In early June, some hope appeared when the FDA agreed that the anti-amyloid antibody lecanemab (to be sold by Eisai as Leqembi) outperformed placebo in trials. It is expected to receive full approval by July 6. But this may not necessarily be purely good news.

FDA 85

FDA 85

Drug Topics

JULY 5, 2023

What are the experiences of patients who had their wound treated in pharmacy settings?

Community Pharmacies 98

Community Pharmacies 98

Pharmaceutical Technology

JULY 5, 2023

The corporate strategy aims to introduce new legislation for faster regulations, new international collaborations, and digitisation.

98

98

European Pharmaceutical Review

JULY 5, 2023

Revised for 2023, the Parenteral Drug Association (PDA) has published an update to its Technical Report No. 43: Identification and Classification of Nonconformities in Moulded and Tubular Glass Containers for Pharmaceutical Manufacturing. The long-awaited PDA TR 43 report provides an approach to a quality decision-making process and represents best practices for the identification and classification of visual nonconformities for (empty) glass containers as pharmaceutical product packaging.

Packaging 81

Packaging Documentation Pharmaceutical Companies Pharmaceutical Companies 81

Drug Store News

JULY 5, 2023

Three limited edition rollerballs are part of the line, which evokes the feeling of summer that brings consumers to the world of Cousins Beach.

89

89